MediumPsychiatryMetabolic monitoring with antipsychoticsau-racpau-amc
A 45-year-old man with schizophrenia has been stable on an atypical antipsychotic for 6 months. Which of the following monitoring strategies is most appropriate regarding metabolic side effects?